General Announcement::Press Release:Collaboration with Hangzhou Normal University to Undertake Clinical Investigations

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
09-Sep-2019 17:33:19
Status
New
Announcement Sub Title
Press Release:Collaboration with Hangzhou Normal University to Undertake Clinical Investigations
Announcement Reference
SG190909OTHRXIR9
Submitted By (Co./ Ind. Name)
Lew Kwang Ping
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Please refer to attachment.

Attachments

Biolidics -HZNU-Press Release Ver5.pdf
Total size =288K